Abstract
BackgroundThe 2008 American College of Rheumatology Recommendations has been updated last year, abatacept (ABT) has become available as the first biologic agent for patients with established RA1. The efficacy and...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have